F-1: Wearable Devices Ltd. Seeks to Raise Capital Through Share and Warrant Offering
Registration Statement
Wearable Devices Ltd. announces a best efforts offering of ordinary shares and warrants to raise capital for working capital and general corporate purposes.
Summary
- Wearable Devices Ltd. is offering ordinary shares and warrants in a best efforts offering.
- The offering includes ordinary shares, warrants to purchase ordinary shares, pre-funded warrants, and ordinary shares underlying such warrants.
- The assumed public offering price is $ per Ordinary Share and accompanying Warrant, based on the last reported sale price of the company's Ordinary Shares on Nasdaq on December 20, 2024.
- Each warrant will have an exercise price of $ per share and will be immediately exercisable, expiring five years from the issuance date.
- Pre-funded warrants are offered to purchasers who would otherwise exceed beneficial ownership limits of 4.99% or 9.99% of outstanding Ordinary Shares.
- The purchase price of each Pre-Funded Warrant will equal the price per share at which the Ordinary Shares are being sold to the public in this offering, minus $0.0001, and the exercise price of each Pre-Funded Warrant will be $0.0001 per share.
- The offering will terminate on February 28, 2025, unless completed sooner or terminated earlier by the company.
- The company intends to use the net proceeds for working capital and general corporate purposes.
- In 2023 and 2022, the company had revenues of $82 thousand and $45 thousand, respectively, and comprehensive and net loss of $7.8 million and $6.5 million, respectively.
- For the six months ended June 30, 2024 and June 30, 2023, the company had revenues of $394 thousand and $12 thousand, respectively, and comprehensive and net loss of $4.2 million and $3.9 million, respectively.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the company's ongoing losses, the auditor's going concern note, and the risks associated with the offering. However, there are some positive aspects, such as the launch of new products and the interest from multinational companies.
Positives
- The company has shipped over one thousand Mudra Bands since the fourth quarter of 2023.
- The company launched the Mudra Link, a universal gesture control wearable wristband, in September 2024, with shipments expected in the first quarter of 2025.
- Over 100 companies have purchased the Mudra Inspire development kit, including 30 multinational technology companies.
Negatives
- The company has a history of net losses, with a $7.8 million loss in 2023 and a $4.2 million loss for the first six months of 2024.
- The company's auditor included an explanatory paragraph in their report regarding the company's ability to continue as a going concern.
- There is no established public trading market for the Warrants and the Pre-Funded Warrants, and the company does not expect a market to develop.
Risks
- The market price of the company's Ordinary Shares may be highly volatile.
- Future issuances of Ordinary Shares may cause the trading price to decline.
- Management has broad discretion as to the use of the proceeds from this offering.
- Purchasers will incur immediate and substantial dilution in the book value of their investment.
- Nasdaq may delist the company's Ordinary Shares if it fails to meet continued listing requirements.
- There is no public market for the Warrants or Pre-Funded Warrants being offered.
- The best efforts structure of this offering may have an adverse effect on the company's business plan.
Future Outlook
The company intends to transform interaction and control of digital devices to be as natural and intuitive as real-life experiences and believes that neural-based interfaces will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen is a universal input method for smartphones.
Industry Context
The company is positioning itself to be a leader in the neural-based interface market, aiming to set the standard input interface for the Metaverse.
Comparison to Industry Standards
- The document does not contain specific comparisons to industry standards or competitors.
- Without specific benchmarks, it's difficult to assess the company's performance relative to industry peers like Apple (Apple Watch), Fitbit (wearable fitness trackers), or companies developing brain-computer interfaces like Neuralink.
Stakeholder Impact
- Shareholders will experience potential dilution from the offering.
- Employees' job security may be affected by the company's financial performance.
- Customers may benefit from the company's continued product development.
- Suppliers may be affected by the company's ability to pay its bills.
- Creditors face increased risk due to the company's financial situation.
Next Steps
- The company will continue to market and sell its Mudra Band and Mudra Link products.
- The company will seek to enter into licensing agreements with B2B customers.
- The company will use the proceeds from the offering for working capital and general corporate purposes.
Key Dates
| Date | Description |
|---|---|
| October 10, 2024 | Reverse Share Split became effective |
| December 20, 2024 | Last reported sale price of Ordinary Shares and IPO Warrants on Nasdaq was $1.87 per share and $0.29 per IPO Warrant, respectively |
| December 23, 2024 | Date of the prospectus |
| First Quarter 2025 | Expected shipment of Mudra Link |
| February 28, 2025 | Offering termination date |
| , 2025 | Expected delivery of securities |
Keywords
offering, warrants, ordinary shares, wearable devices, pre-funded warrants, capital raise, Mudra Band, Nasdaq, best efforts, dilution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.